Orasure Technologies (OSUR) Cash from Financing Activities (2010 - 2025)
Orasure Technologies (OSUR) reported Cash from Financing Activities of -$5.1 million for Q3 2025, down 599.59% on a YoY basis from $1.0 million in Q3 2024, and up 12.4% sequentially from -$5.8 million in Q2 2025.
Orasure Technologies (OSUR) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Orasure Technologies (OSUR) has 16 years of Cash from Financing Activities data on file, last reported at -$5.1 million in Q3 2025.
- For the quarter ending Q3 2025, Cash from Financing Activities fell 599.59% year-over-year to -$5.1 million; the trailing twelve-month figure through Sep 2025 stood at -$11.9 million (down 170.16% YoY), and the FY2024 full-year result was -$4.2 million, down 38.14% from the prior year.
- Cash from Financing Activities improved to -$5.1 million in Q3 2025, from -$5.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $235000.0 in Q4 2021 to a low of -$5.8 million in Q2 2025.
- A 5-year average of -$1.4 million and a median of -$801000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 68.73% in 2024 and slumped 599.59% in 2025, its largest moves.
- Tracing OSUR's Cash from Financing Activities over 5 years: stood at $235000.0 in 2021, then tumbled by 440.85% to -$801000.0 in 2022, then surged by 55.68% to -$355000.0 in 2023, then surged by 68.73% to -$111000.0 in 2024, then plunged by 4475.68% to -$5.1 million in 2025.
- Business Quant data shows OSUR's Cash from Financing Activities at -$5.1 million in Q3 2025, -$5.8 million in Q2 2025, and -$953000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Orasure Technologies | 294.21 Mn | 94.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -5.08 Mn |
| Sep 30, 2025 | -5.08 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Mar 31, 2025 | -953,000.00 |
| Mar 31, 2025 | -953,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -726,000.00 |
| Sep 30, 2024 | -726,000.00 |
| Jun 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | -355,000.00 |
| Dec 31, 2023 | -355,000.00 |
| Sep 30, 2023 | -705,000.00 |
| Sep 30, 2023 | -705,000.00 |
| Jun 30, 2023 | -632,000.00 |
| Jun 30, 2023 | -632,000.00 |